Neisseria gonorrhoeae (P.C.R)
د.إ450.00Sample Type : Dry Swab / Urine
Methodology : Real-time PCR
TAT : 1 Day
Showing 19–24 of 24 results
-
-
Oncomine Acute Myeloid Leukemia (AML) Panel – Targeted NGS Solution for AML Research
د.إ5,500.00The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.
-
Oncomine Myeloproliferative Neoplasm (MPN) Panel – Accurate NGS Testing for MPN Mutations
د.إ5,500.00The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.
-
Oncotype DX Breast Cancer Test – Personalized Risk Assessment & Treatment Guidance
د.إ35,000.00The Oncotype DX Breast Cancer (ML) Test is a genomic assay that analyzes the activity of 21 genes in a breast cancer tumor to predict the risk of recurrence and the potential benefit of chemotherapy. Designed for early-stage, hormone receptor-positive, HER2-negative breast cancer patients, it provides a Recurrence Score® result that helps guide personalized treatment decisions. Key benefits include reducing unnecessary chemotherapy, improving patient outcomes, and offering evidence-based insights backed by extensive clinical validation.
-
STD 8 Panel (Real Time PCR)-Chlamydia Trachomatis, Mycoplasma Genitalium,Trichomonas Vaginalis,Ureaplasma Parvum,Ureaplasma Urealyticum,Mycoplasma Hominis, Neisseria Gonorrhoeae, Gardnerella Vaginalis
د.إ575.00The STD 8 Panel (Real Time PCR) is a comprehensive diagnostic test that detects eight common sexually transmitted pathogens: Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Neisseria gonorrhoeae, and Gardnerella vaginalis. Utilizing advanced real-time PCR technology, it offers high sensitivity and specificity for accurate, early detection.
Sample Type : Dry Swab / Urine
Methodology : PCR
TAT : 1 Day -
Whole Exome Sequencing
د.إ5,375.00Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.